Search Results - "Keränen, Mikko A. I."
-
1
Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia
Published in Leukemia (01-05-2021)“…The prevalence and functional impact of somatic mutations in nonleukemic T cells is not well characterized, although clonal T-cell expansions are common. In…”
Get full text
Journal Article -
2
Enrichment of cancer-predisposing germline variants in adult and pediatric patients with acute lymphoblastic leukemia
Published in Scientific reports (23-06-2022)“…Despite recent progress in acute lymphoblastic leukemia (ALL) therapies, a significant subset of adult and pediatric ALL patients has a dismal prognosis…”
Get full text
Journal Article -
3
Gemtuzumab-Ozogamicin-Related Impaired Hemoglobin-Haptoglobin Scavenging as On-Target/Off-Tumor Toxicity of Anti-CD33 AML Therapy: A Report of Two Cases
Published in Case reports in hematology (22-03-2021)“…Gemtuzumab-ozogamicin (GO) is a humanized anti-CD33 antibody, which is conjugated to a cytotoxic calicheamicin. It is used to treat acute myeloid leukemia…”
Get full text
Journal Article -
4
Clonal hematopoiesis in patients with rheumatoid arthritis
Published in Blood cancer journal (New York) (26-07-2018)Get full text
Journal Article -
5
Ex vivo intracoronary gene transfer of adeno-associated virus 2 leads to superior transduction over serotypes 8 and 9 in rat heart transplants
Published in Transplant international (01-11-2013)“…Heart transplant gene therapy requires vectors with long-lasting gene expression, high cardiotropism, and minimal pathological effects. Here, we examined…”
Get more information
Journal Article -
6
Somatic mTOR mutation in clonally expanded T lymphocytes associated with chronic graft versus host disease
Published in Nature communications (07-05-2020)“…Graft versus host disease (GvHD) is the main complication of allogeneic hematopoietic stem cell transplantation (HSCT). Here we report studies of a patient…”
Get full text
Journal Article -
7
Targeting Lymphatic Vessel Activation and CCL21 Production by Vascular Endothelial Growth Factor Receptor-3 Inhibition Has Novel Immunomodulatory and Antiarteriosclerotic Effects in Cardiac Allografts
Published in Circulation (New York, N.Y.) (30-03-2010)“…Lymphatic network and chemokine-mediated signals are essential for leukocyte traffic during the proximal steps of alloimmune response. We aimed to determine…”
Get full text
Journal Article -
8
Donor Simvastatin Treatment Abolishes Rat Cardiac Allograft Ischemia/Reperfusion Injury and Chronic Rejection Through Microvascular Protection
Published in Circulation (New York, N.Y.) (06-09-2011)“…Ischemia/reperfusion injury may have deleterious short- and long-term consequences for cardiac allografts. The underlying mechanisms involve microvascular…”
Get full text
Journal Article -
9
Platelet-derived Growth Factor-B Protects Rat Cardiac Allografts From Ischemia-reperfusion Injury
Published in Transplantation (01-02-2016)“…BACKGROUNDMicrovascular dysfunction and cardiomyocyte injury are hallmarks of ischemia-reperfusion injury (IRI) after heart transplantation. Platelet-derived…”
Get full text
Journal Article -
10
Author Correction: Clonal hematopoiesis in patients with rheumatoid arthritis
Published in Blood cancer journal (New York) (17-02-2021)“…A Correction to this paper has been published: https://doi.org/10.1038/s41408-021-00427-1…”
Get full text
Journal Article -
11
Integrated drug profiling and CRISPR screening identify essential pathways for CAR T-cell cytotoxicity
Published in Blood (27-02-2020)“…Chimeric antigen receptor (CAR) T-cell therapy has proven effective in relapsed and refractory B-cell malignancies, but resistance and relapses still occur…”
Get full text
Journal Article -
12
Angiogenic growth factors in cardiac allograft rejection
Published in Transplantation (15-07-2006)“…Normal adult vasculature is in a quiescent state. In transplanted hearts, peri- and postoperative ischemic and alloimmune stimuli may be interpreted as…”
Get full text
Conference Proceeding Journal Article -
13
Immunogenomic Landscape of Hematological Malignancies
Published in Cancer cell (14-09-2020)Get full text
Journal Article -
14
Somatic mutations and T-cell clonality in patients with immunodeficiency
Published in Haematologica (Roma) (01-12-2020)“…Common variable immunodeficiency and other late-onset immunodeficiencies often co-manifest with autoimmunity and lymphoproliferation. The pathogenesis of most…”
Get full text
Journal Article -
15
Common Protective and Diverse Smooth Muscle Cell Effects of AAV-Mediated Angiopoietin-1 and -2 Expression in Rat Cardiac Allograft Vasculopathy
Published in Circulation research (09-06-2006)“…Angiopoietin-1 (Ang1) and Ang2 regulate the maintenance of normal vasculature by direct endothelial and indirect smooth muscle cell (SMC) effects. Dysfunction…”
Get full text
Journal Article -
16
VEGFR-1 and -2 Regulate Inflammation, Myocardial Angiogenesis, and Arteriosclerosis in Chronically Rejecting Cardiac Allografts
Published in Arteriosclerosis, thrombosis, and vascular biology (01-04-2007)“…OBJECTIVE—Interplay between inflammation and angiogenesis is important in pathological reparative processes such as arteriosclerosis. We investigated how the…”
Get full text
Journal Article -
17
Somatic mutations associate with clonal expansion of CD8 + T cells
Published in Science advances (07-06-2024)“…Somatic mutations in T cells can cause cancer but also have implications for immunological diseases and cell therapies. The mutation spectrum in nonmalignant T…”
Get full text
Journal Article -
18
PDGF-A, -C, and -D but not PDGF-B Increase TGF-β1 and Chronic Rejection in Rat Cardiac Allografts
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2009)“…Objective— Chronic rejection is the main reason for the poor long-term survival of heart transplant recipients and is characterized by cardiac allograft…”
Get full text
Journal Article -
19
Increased Th17 rather than Th1 alloimmune response is associated with cardiac allograft vasculopathy after hypothermic preservation in the rat
Published in The Journal of heart and lung transplantation (01-09-2010)“…Background Preservation injury decreases patient survival and promotes the development of cardiac allograft vasculopathy. We investigated the sequential…”
Get full text
Journal Article -
20
Immunogenomic Landscape of Hematological Malignancies
Published in Cancer cell (14-09-2020)“…Understanding factors that shape the immune landscape across hematological malignancies is essential for immunotherapy development. We integrated over 8,000…”
Get full text
Journal Article